271 related articles for article (PubMed ID: 27604166)
1. Advances in understanding prognosis in myeloma.
Smith D; Yong K
Br J Haematol; 2016 Nov; 175(3):367-380. PubMed ID: 27604166
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for multiple myeloma in the era of novel therapies.
Ziogas DC; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2018 Nov; 11(11):863-879. PubMed ID: 30334460
[TBL] [Abstract][Full Text] [Related]
3. Current Review on High-Risk Multiple Myeloma.
Chan HSH; Chen CI; Reece DE
Curr Hematol Malig Rep; 2017 Apr; 12(2):96-108. PubMed ID: 28317082
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: is it time for biomarker-driven therapy?
Bhutani M; Landgren O; Usmani SZ
Am Soc Clin Oncol Educ Book; 2015; ():e493-503. PubMed ID: 25993214
[TBL] [Abstract][Full Text] [Related]
5. The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y; Mishima Y; Shirouchi Y; Nishimura N; Yokoyama M; Okabe T; Inoue N; Uryu H; Fukuta T; Hatake K; Terui Y
Int J Hematol; 2021 Feb; 113(2):279-284. PubMed ID: 32864713
[TBL] [Abstract][Full Text] [Related]
6. High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.
Muchtar E; Magen H; Gertz MA
Leuk Lymphoma; 2017 Jun; 58(6):1283-1296. PubMed ID: 27734720
[TBL] [Abstract][Full Text] [Related]
7. Towards Stratified Medicine in Plasma Cell Myeloma.
Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors].
Zdziarska B
Ann Acad Med Stetin; 1990; 36():179-94. PubMed ID: 2099106
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
[TBL] [Abstract][Full Text] [Related]
10. Better therapy requires better response evaluation: Paving the way for minimal residual disease testing for every myeloma patient.
Landgren O; Owen RG
Cytometry B Clin Cytom; 2016 Jan; 90(1):14-20. PubMed ID: 26147584
[TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
[TBL] [Abstract][Full Text] [Related]
12. Myeloma genetics and genomics: practice implications and future directions.
Faiman B
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):436-40. PubMed ID: 25127058
[TBL] [Abstract][Full Text] [Related]
13. Novel biomarkers in multiple myeloma.
Levin A; Hari P; Dhakal B
Transl Res; 2018 Nov; 201():49-59. PubMed ID: 30301522
[TBL] [Abstract][Full Text] [Related]
14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
15. Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.
Siegel DS; Vij R; Jakubowiak AJ
Clin Adv Hematol Oncol; 2011 Apr; 9(4):1-15. PubMed ID: 21928467
[TBL] [Abstract][Full Text] [Related]
16. [Multiple myeloma].
Peest D
Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
[TBL] [Abstract][Full Text] [Related]
17. An update of the management of multiple myeloma: the changing landscape.
Reece DE
Hematology Am Soc Hematol Educ Program; 2005; ():353-9. PubMed ID: 16304403
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive biomarker developments in multiple myeloma.
Wallington-Beddoe CT; Mynott RL
J Hematol Oncol; 2021 Sep; 14(1):151. PubMed ID: 34556161
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
Stewart AK; Fonseca R
J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: Every year a new standard?
Rajkumar SV
Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl 1):62-65. PubMed ID: 31187526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
